Beam gets green light to begin first clinical test of base editing
Gene editing's promise is clearest, and perhaps closest, in sickle cell disease, a hereditary condition characterized by deformed, or "sickled," red blood cells that ...
IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.